Logo

Amneal Pharmaceuticals, Inc.

AMRX

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmi… read more

Healthcare

Drug Manufacturers—Specialty & Generic

6 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$9.45

Price

+0.64%

$0.06

Market Cap

$2.968b

Mid

Price/Earnings

945x

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-1.6%

EBITDA Margin

-13.9%

Net Profit Margin

-3.7%

Free Cash Flow Margin
Revenue

$2.853b

+4.3%

1y CAGR

+6.0%

3y CAGR

+5.8%

5y CAGR
Earnings

$3.375m

-100.8%

1y CAGR

-465.7%

3y CAGR

-366.9%

5y CAGR
EPS

$0.01

-16.7%

1y CAGR

-448.4%

3y CAGR

-354.2%

5y CAGR
Book Value

-$46.731m

$3.423b

Assets

$3.470b

Liabilities

$2.582b

Debt
Debt to Assets

75.4%

8.9x

Debt to EBITDA
Free Cash Flow

$262.479m

-55.0%

1y CAGR

+338.5%

3y CAGR

+244.0%

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases